Gujarat perhaps going to be the next hub of Indian healthcare enterprise. After Vicks and Colgate Palmolive, US-based Abbott Laboratories plan to set up a manufacturing unit in Gujarat to produce its nutraceutical range-Ensure and PediaSure at Jhagadia.
Abbott has acquired 45 acres of land for the plant, which will be its second unit in India. It will be set up with an initial investment of Rs 360 crore.Several leading global pharma and FMCG companies are eyeing the state for greenfield projects. Israels Teva Pharmaceutical Industries along with the USbased Procter & Gamble is setting up a Rs 500 crore plant to manufacture its Vicks range of products in Sanand.
Scotland-based pharma and lifesciences companies are also eyeing Gujarat for an entry into the Indian market. Mark Dolan, country manager, Scottish Development International attributes the trend to the quick materialisation of discussions. Gujarati and Scottish businesses hold many common values and attitudes. Every opportunity to meet and discuss business is maximised with discussion quickly getting down to detail. Dolan met a couple of pharmaceutical and lifesciences companies in Ahmedabad in the first week of August to explore business opportunities.